InnovAge Holding Corp.

INNV

US45784A1043

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
3.85 ^USD	-5.64%		-10.88%	-35.83%

May. 07	InnovAge Holding Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI
May. 07	Earnings Flash (INNV) INNOVAGE Reports Q3 Revenue $193.1M, vs. Street Est of $188.3M	MT

InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2022

September 21, 2021 at 04:05 pm EDT

InnovAge Holding Corp. provided earnings guidance for the full fiscal year 2022. For the year, the company expects total revenues to be between $712,000 to $725,000.

Latest news about InnovAge Holding Corp.

InnovAge Holding Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 07	CI
Earnings Flash (INNV) INNOVAGE Reports Q3 Revenue $193.1M, vs. Street Est of $188.3M	May. 07	MT
(INNV) INNOVAGE Forecasts Fiscal Year 2024 Revenue Range $725M - $775M	May. 07	MT
Transcript : InnovAge Holding Corp., Q3 2024 Earnings Call, May 07, 2024	May. 07
InnovAge Holding Corp. Reiterates Financial Guidance for the Full Fiscal Year 2024	May. 07	CI
InnovAge Holding Corp. Launches PACE Center in Los Angeles	Apr. 24	CI
JPMorgan Adjusts Price Target on InnovAge to $6 From $7, Maintains Neutral Rating	Mar. 13	MT
InnovAge Holding Corp. Launches New Center in Tampa, its First in the State of Florida	Mar. 04	CI
Transcript : InnovAge Holding Corp. - Analyst/Investor Day	Feb. 27
Goldman Sachs Trims Price Target on InnovAge Holding to $7 From $8, Maintains Neutral Rating	Feb. 08	MT
Transcript : InnovAge Holding Corp., Q2 2024 Earnings Call, Feb 06, 2024	Feb. 06
(INNV) INNOVAGE Expects Fiscal Year 2023 Revenue Range $725M - $775M	Feb. 06	MT
Earnings Flash (INNV) INNOVAGE Posts Q2 Revenue $188.9M, vs. Street Est of $184M	Feb. 06	MT
InnovAge Holding Corp. Provides Earnings Guidance for the Full Fiscal Year 2024	Feb. 06	CI
InnovAge Holding Corp. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Feb. 06	CI
InnovAge Acquires Two PACE Programs in California From ConcertoCare	Dec. 01	MT
InnovAge Holding Corp. Reports Earnings Results for the First Quarter Ended September 30, 2023	Nov. 07	CI
Transcript : InnovAge Holding Corp., Q1 2024 Earnings Call, Nov 07, 2023	Nov. 07
Earnings Flash (INNV) INNOVAGE Reports Q1 Revenue $182.5M, vs. Street Est of $178.4M	Nov. 07	MT
InnovAge Holding Appoints New Chief Nursing Officer	23-10-02	MT
Innovage Holding Corp. Names Darlene Flaig as New Chief Nursing Officer	23-10-02	CI
JPMorgan Adjusts InnovAge Price Target to $7 From $8, Maintains Neutral Rating	23-09-18	MT
InnovAge Holding Corp.(NasdaqGS:INNV) dropped from S&P Global BMI Index	23-09-18	CI
Earnings Flash (INNV) INNOVAGE Reports Q4 Revenue $176.9M, vs. Street Est of $175.8M	23-09-12	MT
InnovAge Holding Corp. Reports Earnings Results for the Full Year Ended June 30, 2023	23-09-12	CI

InnovAge Holding Corp. is a healthcare delivery platform. It is focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. The Company's programs are designed to allow frail seniors to live life on their terms by aging in place, in their own homes and communities, for as long as safely possible. Through its Program of All-Inclusive Care for the Elderly (PACE) program, it fulfills a range of medical and ancillary services for seniors, including in-home care services (skilled, unskilled and personal care), center services such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to and from the PACE center and third-party medical appointments; and care management. Its participant-centered approach is led by the Company's Interdisciplinary Care Teams (IDTs), who design, manage and coordinate each participants personalized care plan.

Sector

Healthcare Facilities & Services

Calendar

2024-09-09 - Q4 2024 Earnings Release (Projected)

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for InnovAge Holding Corp.

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

4.08 USD

Average target price

6 USD

Spread / Average Target

+47.06%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
INNOVAGE HOLDING CORP.	-35.83%	555M
HCA HEALTHCARE, INC.	+17.18%	85.55B
CVS HEALTH CORPORATION	-28.48%	70.07B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+6.76%	28.95B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-7.44%	17.51B
FRESENIUS SE & CO. KGAA	+2.14%	17.39B
QUEST DIAGNOSTICS INCORPORATED	+2.10%	15.38B
REDE D'OR SÃO LUIZ S.A.	+7.02%	13.4B
NATERA, INC.	+64.96%	12.93B
FRESENIUS MEDICAL CARE AG	+6.64%	12.77B

Other Healthcare Facilities & Services